학술논문
979P Safety interim analyses of first-line systemic therapy with atezolizumab plus bevacizumab (ATZ+BEV) in patients from Spain with unresectable hepatocellular carcinoma (HCC): Phase IIIb ATHECA
Document Type
Abstract
Author
Source
In Annals of Oncology October 2023 34 Supplement 2:S606-S607
Subject
Language
ISSN
0923-7534